longbridge
  • Explore
    Products
    Private Wealth ManagementUS StocksSG StocksHK StocksUS OptionsUS Pre-Market OptionsETFsREITsWarrantsCash Plus
    Tools
    Longbridge SkillLongbridge AILongbridge APIPaper TradingDividend HubLongbridge Pro
  • Café
longbridge

OCUMENSION-B

1477

4.8600.52% ( +0.025 )
Delay Closed: Nov 18, 16:08:04
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile

News

  • Ocumension climbs 6% in Hong Kong trading

    Market Movers·Nov 18, 2026 at 02:20 AM
    01477+0.52%
  • OCUMENSION-B rose approximately 10%

    Market Movers·Nov 17, 2026 at 02:01 AM
    01477+0.52%
  • Ocumension drops 6% in Hong Kong trading

    Market Movers·Nov 16, 2026 at 02:30 AM
    01477+0.52%
  • OCUMENSION-B rose approximately 7%

    Market Movers·Nov 13, 2026 at 02:00 AM
    01477+0.52%
  • Ocumension falls nearly 7% in Hong Kong trading

    Market Movers·Nov 3, 2026 at 01:30 AM
    01477+0.52%
  • OCUMENSION-B rose approximately 8%

    Market Movers·Oct 30, 2026 at 03:07 AM
    01477+0.52%
  • Ocumension climbs 7% on NMPA approval for implant production

    Market Movers·Oct 28, 2026 at 05:14 AM
    01477+0.52%
  • Ocumension Phase III Myopia Drug OT-101 Hits Primary Goal in China Cohort

    Tip Ranks·Oct 20, 2026 at 12:38 AM
    01477+0.52%
  • Ocumension Biopharma drops 2% in Hong Kong on glaucoma drug filing

    HK Stock Market Update·Sep 22, 2026 at 01:43 AM
    01477+0.52%
  • Nicox Announces NCX 470 NDA in China Accepted for Review

    GlobeNewswire·Sep 11, 2026 at 05:30 AM
    01477+0.52%
  • Ocumension says China NMPA accepts OT-301 glaucoma drug application

    PUBT·Sep 10, 2026 at 11:00 PM
    01477+0.52%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy